Dual Inhibition of HER2 and VEGF Pathways in Breast Cancer: A Meta-analysis of Outcomes. Qureshi Z, Jamil A, Samsuddoha K, Kahlon N, et al. Am J Clin Oncol 2025 Dec 29. doi: 10.1097/COC.0000000000001293.

Read + Share

Amedeo Smart

Independent Medical Education

Qureshi Z, Jamil A, Samsuddoha K, Kahlon N, et al. Dual Inhibition of HER2 and VEGF Pathways in Breast Cancer: A Meta-analysis of Outcomes. Am J Clin Oncol 2025 Dec 29. doi: 10.1097/COC.0000000000001293.
PMID: 41459979